Influence of GYKI-13504, a New Antioestrogen, on the Responsiveness of Isolated Uterus Removed from Oestradiol Pretreated Rats to PGF2α

J. Borvendég; Zs. Anheuer

doi:10.1055/s-0029-1210512

Subscribe to RSS

Please copy the URL and add it into your RSS Feed Reader.

https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000017.xml

Share / Bookmark

Facebook X Linkedin Weibo

Download PDF

Exp Clin Endocrinol Diabetes 1985; 86(6): 368-370
DOI: 10.1055/s-0029-1210512

Short Communication

Influence of GYKI-13504, a New Antioestrogen, on the Responsiveness of Isolated Uterus Removed from Oestradiol Pretreated Rats to PGF₂α

J. Borvendég, Zs. Anheuer

National Institute of Pharmacy Budapest/Hungary

Further Information

Publication History

1985

Publication Date:
16 July 2009 (online)

Also available at

PDF Download Permissions and Reprints

Summary

The responsiveness of the uteri of ovariectomized rats pretreated either with E₂ or with a new antioestrogen, GYKI-13 504 or with both agents simultaneously to PGF₂α was studied in vitro. The treatment with E₂ caused a fortyfold reduction in the responsiveness of the uterus to PGF₂α. GYKI-13 504 itself did not influence the sensitivity of this organ significantly, but inhibited the diminishing effect of E₂.

Key words

Antioestrogen - PGF₂α - Uterus-responsiveness